INTELLIGENT BIO SOLUTIONS INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$684.74 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $559.31K, a 82.14% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$722.40K, a 404.55% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $45.45K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$567.11K, a 356.22% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2026 was -$684.74K, a 126.57% decline from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2025 was $2.58M.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was -$632.95K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $559.31K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$163.08K derived: sum of 2 quarters · filed 2026-08-19 | -$117.63K derived: sum of 3 quarters · filed 2026-08-19 | -$684.74K 10-K · filed 2026-08-19 |
| 2026-03-31 | -$722.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$676.95K derived: sum of 2 quarters · filed 2026-05-13 | -$1.24M 10-Q · filed 2026-05-13 | $1.89M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $45.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$521.66K 10-Q · filed 2026-02-12 | $2.61M derived: sum of 3 quarters · filed 2026-08-19 | $2.85M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | -$567.11K 10-Q · filed 2025-11-12 | $2.56M derived: sum of 2 quarters · filed 2026-08-19 | $2.80M derived: sum of 3 quarters · filed 2026-08-19 | $1.79M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $3.37M derived: sum of 2 quarters · filed 2026-08-19 | $2.36M derived: sum of 3 quarters · filed 2026-08-19 | $2.58M 10-K · filed 2026-08-19 |
| 2025-03-31 | $237.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$776.18K derived: sum of 2 quarters · filed 2026-05-13 | -$554.85K 10-Q · filed 2026-05-13 | -$973.49K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$792.05K 10-Q · filed 2026-02-12 | -$1.21M derived: sum of 3 quarters · filed 2026-02-12 | |
| 2024-09-30 | $221.34K 10-Q · filed 2025-11-12 | -$197.31K derived: sum of 2 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$418.64K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | -$632.95K 10-K · filed 2025-08-15 | ||
| 2024-03-31 | -$214.31K 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |